Combined effects of leukocyte telomere length, p53 polymorphism and human papillomavirus infection on esophageal squamous cell carcinoma in a Han Chinese population

被引:11
|
作者
Yu, Qianqian [1 ]
Yang, Ju [1 ]
Liu, Bo [1 ]
Li, Wen [1 ]
Hu, Guangyuan [1 ]
Qiu, Hong [1 ]
Huang, Liu [1 ]
Xiong, Huihua [1 ]
Yuan, Xianglin [1 ]
机构
[1] Huazhong Univ Sci & Technol, Dept Oncol, Tongji Hosp, Wuhan 430074, Hubei Province, Peoples R China
基金
中国国家自然科学基金;
关键词
Esophageal squamous cell carcinoma; Telomere length; p53; Human papillomavirus 16; CLINICAL-SIGNIFICANCE; MDM2; POLYMORPHISMS; RISK; CANCER; ASSOCIATION; IMMORTALIZATION; SENESCENCE; EXPRESSION; HPV; E6;
D O I
10.1016/j.canep.2014.07.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Telomere shortening has been suggested to be a genetic predictor for various cancers. However, evidences about this point with respect to esophageal squamous cell carcinoma (ESCC) in Han Chinese populations remain limited. Our previous study demonstrated that p53 Arg72Pro polymorphism was associated with the risk of human papillomavirus (HPV)-related ESCC. Telomeres and p53 play important roles in maintaining genomic stability and regulating the cell cycle. HPV impacts both telomere length stabilization and p53 degradation. Given the roles of the three factors, we evaluated leukocyte telomere length, p53 variants and HPV-16 serology to examine the potential associations between them and ESCC risk in a case-control study with 308 patients and 309 cancer-free controls matched by age and sex. Compared with long telomere length, short telomere length was significantly associated with an increased risk of ESCC (adjusted OR 2.01; 95% CI 1.41-2.80). Moreover, this association was enhanced when combined with HPV-16 seropositivity and p53 Arg/Arg or Arg/Pro genotypes. Notably, individuals with short telomere length, Arg/Pro or Arg/Arg genotypes and HPV-16 seropositivity had a 12.08-fold (95% CI 5.49-26.56) increased risk of ESCC compared to those with none of the three investigated risk factors. Taken together, these results indicate that short telomere length in peripheral blood leukocytes is a biomarker for ESCC risk, and has statistically additive effects with p53 variants and HPV seropositivity with regard to the risk of ESCC in a Han Chinese population. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:569 / 575
页数:7
相关论文
共 50 条
  • [1] Human papillomavirus infection increases the chemoradiation response of esophageal squamous cell carcinoma based on P53 mutation
    Zhang, Dakai
    Zhang, Wei
    Liu, Wenzhi
    Mao, Yu
    Fu, Zhanzhao
    Liu, Jia
    Huang, Wei
    Zhang, Zicheng
    An, Dianzheng
    Li, Baosheng
    RADIOTHERAPY AND ONCOLOGY, 2017, 124 (01) : 155 - 160
  • [2] Human papillomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma
    Hoffmann, Markus
    Scheunemann, David
    Fazel, Asita
    Goeroegh, Tibor
    Kahn, Tomas
    Gottschlich, Stefan
    ONCOLOGY REPORTS, 2009, 21 (03) : 809 - 814
  • [3] p53 expression but not p16INK4A correlates with human papillomavirus-associated esophageal squamous cell carcinoma in Kazakh population
    Wang, Lianghai
    Li, Jing
    Hou, Jun
    Li, Man
    Cui, Xiaobin
    Li, Shugang
    Yu, Xiaodan
    Zhang, Zhiyu
    Liang, Weihua
    Jiang, Jinfang
    Pang, Lijuan
    Chen, Yunzhao
    Zhao, Jin
    Li, Feng
    INFECTIOUS AGENTS AND CANCER, 2016, 11
  • [4] Genetic variants affecting telomere length are associated with the prognosis of esophageal squamous cell carcinoma in a Chinese population
    Lu, Yue
    Yan, Caiwang
    Du, Jiangbo
    Ji, Yong
    Gao, Yong
    Zhu, Xun
    Yu, Fei
    Huang, Tongtong
    Dai, Juncheng
    Ma, Hongxia
    Jiang, Yue
    Chen, Jiaping
    Shen, Hongbing
    Jin, Guangfu
    Yin, Yongmei
    Hu, Zhibin
    MOLECULAR CARCINOGENESIS, 2017, 56 (03) : 1021 - 1029
  • [5] P53 codon 72 polymorphism, human papillomavirus infection, and their interaction to oral carcinoma susceptibility
    Hou, Jun
    Gu, Ying
    Hou, Wei
    Wu, Song
    Lou, Yin
    Yang, Wenyu
    Zhu, Ling
    Hu, Yukun
    Sun, Ming
    Xue, Haowei
    BMC GENETICS, 2015, 16
  • [6] Combined effects of p53 gene therapy and leptomycin B in human esophageal squamous cell carcinoma
    Hoshino, Isamu
    Matsubara, Hisahiro
    Komatsu, Aki
    Akutsu, Yasunori
    Nishimori, Takanori
    Yoneyama, Yasuo
    Murakami, Kentaro
    Sakata, Haruhito
    Matsushita, Kazuyuki
    Miyazawa, Yukimasa
    Brooks, Ryan
    Yoshida, Minoru
    Ochiai, Takenori
    ONCOLOGY, 2008, 75 (1-2) : 113 - 119
  • [7] Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population
    Maruyama, Hiromi
    Yasui, Toshimichi
    Ishikawa-Fujiwara, Tomoko
    Morii, Eiichi
    Yamamoto, Yoshifumi
    Yoshii, Tadashi
    Takenaka, Yukinori
    Nakahara, Susumu
    Todo, Takeshi
    Hongyo, Tadashi
    Inohara, Hidenori
    CANCER SCIENCE, 2014, 105 (04): : 409 - 417
  • [8] Human papillomavirus infection and p53 mutation in esophageal squamous cell carcinoma and its impact on treatment outcome
    Singh, Tanmay
    Shirazi, Nadia
    Bansal, Saurabh
    Gupta, Meenu
    Saini, Sunil
    Ahmad, Mushtaq
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 : S150 - S155
  • [9] P53 codon 72 polymorphism and the risk of esophageal squamous cell carcinoma
    Yang, Wenjun
    Zhang, Yanyan
    Tian, Xiuyun
    Ning, Tao
    Ke, Yang
    MOLECULAR CARCINOGENESIS, 2008, 47 (02) : 100 - 104
  • [10] P53 gene codon 72 polymorphism and risk of esophageal squamous cell carcinoma: a case/control study in a Chinese population
    Shao, Y.
    Tan, W.
    Zhang, S.
    DISEASES OF THE ESOPHAGUS, 2008, 21 (02): : 139 - 143